MiMedx Group Affirms FY2026 Sales Guidance of $260.000M-$290.000M vs $269.440M Est

Benzinga Newsdesk www.benzinga.com Negative 71.0%

Neg 71% Neu 0% Pos 0%

MiMedx Group (NASDAQ:MDXG) affirms FY2026 sales outlook from $260.000 million-$290.000 million to $260.000 million-$290.000 million vs $269.440 million estimate.